Martin Schiller

Request as Media Expert

Executive Director, Nevada Institute of Personalized Medicine

Professor of Life Sciences

Expertise: AIDS/HIV, Alzheimer's disease, Genetics, Bioinformatics, CRISPR gene editing

Biography

Martin Schiller's work is focused on short functional peptides, bioinformatics, and HIV. Schiller’s research has resulted in 60 publications supported mostly by 12 research grants from the National Institutes of Health.

He has received a number of awards, produced a suite of bioinformatics tools, and is involved in commercialization of some of his research projects. He is now the executive director of the Nevada Institute of Personalized Medicine.

Search For Other Experts On

biology, science & technology

Martin Schiller In The News

5 Traits You Probably Got From Your Parents—Besides Eye Color

Giddy

Your genes govern appearance and blood type, but they're also responsible for a whole lot more.

CRISPR breaks ground as a one-shot treatment for a rare disease

Popular Science

CRISPR reached a big milestone this year by treating a disease inside the body—here's what's next for the technology.

Heligenics AND The Jackson Laboratory announce new collaboration on ERBB2 breast cancer gene

EurekAlert!

Heligenics, Inc. today announced a new collaboration with The Jackson Laboratory. This joint project will make available the functional output of Variants of Unknown Significance throughout key portion of the ERBB2 gene through the JAX Clinical Knowledgebase, a digital resource that connects clinicians and researchers around the globe in order to interpret complex cancer genomic profiles.

Heligenics & The Jackson Laboratory Announce New Collaboration on ERBB2 Breast Cancer Gene

PR Newswire

Heligenics, Inc. today announced a new collaboration with The Jackson Laboratory (JAX). This joint project will make available the functional output of Variants of Unknown Significance (VUS) throughout key portion of the ERBB2 gene through the JAX Clinical Knowledgebase (CKB), a digital resource that connects clinicians and researchers around the globe in order to interpret complex cancer genomic profiles.